论文部分内容阅读
本文探讨优泌乐50对初发2型糖尿病患者的疗效,报告如下。1资料与方法1.1临床资料选取我科2011年5月至2012年10月初发2型糖尿病住院患者60例,按用药类型分为两组,优泌乐50组30例,男14例,女16例,年龄23~65岁,平均(48.5±8.6)岁;优泌林70/30组30例,男15例,女15例,年龄25~68岁,平均(49.2±7.4)岁,两组均符合1999年WHO糖尿病诊断标准,排除应激状态、严重肝肾疾病、心功能不全、酮症酸中毒及其他
This article discusses the Uehara 50 pairs of newly diagnosed type 2 diabetes patients, the report is as follows. 1 Materials and Methods 1.1 Clinical data selected in our department from May 2011 to October 2012 early onset of type 2 diabetes inpatients 60 cases, divided into two groups according to the type of drug, 50 cases of Urged 50 patients, 14 males and 16 females (Age range, 23-65 years old, mean (48.5 ± 8.6) years); Youguilin 70/30 group 30 cases, 15 males and 15 females, aged from 25 to 68 years, with an average of (49.2 ± 7.4) years, two groups Are in line with the 1999 WHO diagnostic criteria for diabetes, excluding stress, severe liver and kidney disease, cardiac insufficiency, ketoacidosis and other